The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Rhesus NOV ORF mammalian expression plasmid, C-GFPSpark tag||CG90081-ACG|
|Rhesus NOV ORF mammalian expression plasmid, C-OFPSpark / RFP tag||CG90081-ACR|
|Rhesus NOV ORF mammalian expression plasmid, C-Flag tag||CG90081-CF|
|Rhesus NOV ORF mammalian expression plasmid, C-His tag||CG90081-CH|
|Rhesus NOV ORF mammalian expression plasmid, C-Myc tag||CG90081-CM|
|Rhesus NOV ORF mammalian expression plasmid, C-HA tag||CG90081-CY|
|Rhesus NOV ORF mammalian expression plasmid, N-Flag tag||CG90081-NF|
|Rhesus NOV ORF mammalian expression plasmid, N-His tag||CG90081-NH|
|Rhesus NOV ORF mammalian expression plasmid, N-Myc tag||CG90081-NM|
|Rhesus NOV ORF mammalian expression plasmid, N-HA tag||CG90081-NY|
|Rhesus NOV natural ORF mammalian expression plasmid||CG90081-UT|
|Learn more about expression Vectors|
Protein NOV homolog, also known as Nephroblastoma-overexpressed gene protein homolog, NOV, and CCN3, is a putative ligand for integrin receptors, is tightly associated with the extracellular matrix and mediates diverse cellular functions, including cell adhesion and proliferation. CCN3 has been shown to negatively regulate growth although it promotes migration in a cell type-specific manner. This secreted protein belongs to the CCN family, and its expression was observed in a broad variety of tissues from the early stage of development , and altered expression of CCN3 has been observed in a variety of tumors, including hepatocellular carcinomas, Wilm's tumors, Ewing's sarcomas, gliomas, rhabdomyosarcomas, and adrenocortical carcinomas. Mature CCN3 protein has five distinct modules and truncated protein variants with altered function are found in many cancers. CCN3 acts through the core stem cell signalling pathways including Notch and Bone Morphogenic Protein, connecting CCN3 with the modulation of self-renewal and maturation of a number of cell lineages including hematopoietic, osteogenic and chondrogenic. CCN3 may affect the extracellular environment of the niche for hematopoietic stem cells. CCN3 has emerged as a key player in stem cell regulation, hematopoiesis and a crucial component within the bone marrow microenvironment.